OSF Healthcare System
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, OSF Healthcare System sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
OSF Healthcare System: 14 sponsored US clinical trials, 1 recruiting.
OSF Healthcare System sponsors 14 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 8 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Resilience, with 1 trials.
Top-decile sponsor footprint
OSF Healthcare System ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
14 total, page 1 of 1
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
NCT05555095
Ethics Education to Support Nurse Leaders in HealthCare
NCT06470984
Interprofessional Group Intervention to Enhance Compassion Satisfaction and Resilience
NCT04888000
Observational Study of COVID-19 Treatment Efficacy
NCT04369989
Check Brain Temp Trial
NCT04612101
A STEP for Patients Prior to Undergoing TAVR: A Pilot Study
NCT02766075
Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016
NCT02534714
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
NCT02391818
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
NCT01971359
Using fMRI to Determine if Cerebral Hemodynamic Responses to Pain Change Following Thoracic Spine Manipulation in Individuals With Mechanical Neck Pain
NCT01862705
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
NCT02083367
Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake
NCT01994018
Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
NCT00961753
Intravenous Fat Emulsions and Premature Infants
NCT01096446
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where OSF Healthcare System enrollment is open (later-stage tilt)
1 recruiting of 14 indexed (7% open); 8 completed (57%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Resilience (1 trial), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
OSF Healthcare System: open-pipeline peers nationwide
Peers matched on 14 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
OSF Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 trials (± recruiting share)
- 3-C Institute for Social Development · 14 trials · 0% recruiting
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Carol Fabian, MD · 7% recruiting · 14 trials
- Celldex Therapeutics · 7% recruiting · 42 trials
- Kaiser Permanente · 7% recruiting · 294 trials
- Mannkind Corporation · 7% recruiting · 42 trials
Related
What to do with this OSF Healthcare System page
14 registered trials is a research-attention snapshot, not an endorsement of OSF Healthcare System or any single study.
- 1 of OSF Healthcare System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Resilience is the condition OSF Healthcare System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Resilience trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
OSF Healthcare System pipeline card: 14 registered trials from official public datasets.Report a data error.